Peiguo Wang
Impact in
- Otorhinolaryngology top 1%
- Head and Neck Cancer Studies
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Head and Neck Cancer Studies 11
-
- Ultrasound Imaging and Elastography 3
- Co-authors
- Li Jia (3 shared papers)Jing Zhao (2 shared papers)Qi Pang (1 shared paper)Yufang Zhu (1 shared paper)Jun Xu (1 shared paper)Rongjie Tao (1 shared paper)Guan Sun (1 shared paper)Fengting Liu (2 shared papers)
- Journals
- International Journal of Molecular Sciences (4 papers)OncoTargets and Therapy (3 papers)BMC Cancer (2 papers)Oncology Reports (2 papers)Medicine (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Peiguo Wang
40 papers receiving 1.1k citations
Peiguo Wang's Hit Papers
Peers
Comparison fields: 5 of 89
- Otorhinolaryngology 403
- Cancer Research 139
- Oncology 222
- Pulmonary and Respiratory Medicine 143
- Clinical Biochemistry 24
Countries citing papers authored by Peiguo Wang
This map shows the geographic impact of Peiguo Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peiguo Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peiguo Wang more than expected).
Fields of papers citing papers by Peiguo Wang
This network shows the impact of papers produced by Peiguo Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peiguo Wang. The network helps show where Peiguo Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Peiguo Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Camrelizumab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (CAPTAIN-1st): a multicentre, randomised, double-blind, phase 3 trial Hit paper breakdown → | 2021 | 330 |
| 2 | The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma Hit paper breakdown → | 2021 | 273 |
| 3 | 2011 | 82 | |
| 4 | 2015 | 77 | |
| 5 | 2015 | 40 | |
| 6 | 2018 | 38 | |
| 7 | 2017 | 30 | |
| 8 | 2019 | 30 | |
| 9 | 2018 | 30 | |
| 10 | 2015 | 22 | |
| 11 | 2018 | 20 | |
| 12 | 2022 | 20 | |
| 13 | 2016 | 14 | |
| 14 | 2017 | 14 | |
| 15 | 2015 | 12 | |
| 16 | 2019 | 12 | |
| 17 | 2022 | 12 | |
| 18 | 2020 | 12 | |
| 19 | 2019 | 11 | |
| 20 | 2023 | 10 |
About Peiguo Wang
Peiguo Wang is a scholar working on Otorhinolaryngology, Radiology, Nuclear Medicine and Imaging, Plant Science, Pulmonary and Respiratory Medicine and Speech and Hearing, having authored 46 papers that have together received 1.2k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (11 papers), Soybean genetics and cultivation (9 papers), Legume Nitrogen Fixing Symbiosis (7 papers), Plant Molecular Biology Research (4 papers), Ultrasound and Hyperthermia Applications (4 papers), Plant nutrient uptake and metabolism (4 papers), Colorectal and Anal Carcinomas (3 papers) and Ultrasound Imaging and Elastography (3 papers). The work is most often cited by research in Otorhinolaryngology (403 citations), Cancer Research (139 citations), Oncology (222 citations), Pulmonary and Respiratory Medicine (143 citations) and Clinical Biochemistry (24 citations). Peiguo Wang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Li Jia, Jing Zhao, Qi Pang, Yufang Zhu, Jun Xu, Rongjie Tao, Guan Sun, Fengting Liu, Xiao Yue and Ximei Zhang. Their work appears in journals such as International Journal of Molecular Sciences, OncoTargets and Therapy, BMC Cancer, Oncology Reports and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.